Tests by the National Medicines Institute showed that the product does not meet the quality specification for mebeverine hydrochloride release – release after 2, 8 and 12 hours was below the lower acceptance limit, affecting the product’s effectiveness. Potential effects: lack or reduction of therapeutic efficacy, possible worsening of disease symptoms.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product with GTIN 05909991425289 and 05909991425296; patients who have this medicine should consult a doctor or pharmacist to obtain suitable alternative therapy.
Following the negative quality test results from the National Medicines Institute and a prior suspension of distribution, the Chief Pharmaceutical Inspector issued a decision banning the placing on th...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related